No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
OCUL240517C15000
- 0.05
- 0.000.00%
15min DelayTrading Apr 18 10:53 ET
0.00High0.00Low
0.00Open0.05Pre Close0 Volume0 Open Interest15.00Strike Price0.00Turnover0.00%IV152.94%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier-5DDays to Expiry0.05Time Value100Contract SizeAmericanOptions Type--Delta--Gamma119.00Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- 1D
News
Analysts Have Conflicting Sentiments on These Healthcare Companies: Immunocore Holdings (IMCR), Warby Parker (WRBY) and Ocular Therapeutix (OCUL)
Ocular Therapeutix Price Target Cut to $14.00/Share From $16.00 by HC Wainwright & Co.
Ocular Therapeutix Price Target Cut to $14.00/Share From $16.00 by HC Wainwright & Co.
Ocular Therapeutix Is Maintained at Buy by HC Wainwright & Co.
Ocular Therapeutix Is Maintained at Buy by HC Wainwright & Co.
HC Wainwright & Co. : The Ocular Therapeutix (OCUL.US) rating was maintained, adjusted from buy to buy rating, and the target price was adjusted from $16.00 to $14.00.
HC Wainwright & Co. : The Ocular Therapeutix (OCUL.US) rating was maintained, adjusted from buy to buy rating, and the target price was adjusted from $16.00 to $14.00.
HC Wainwright & Co. Maintains Buy on Ocular Therapeutix, Lowers Price Target to $14
HC Wainwright & Co. analyst Yi Chen maintains Ocular Therapeutix (NASDAQ:OCUL) with a Buy and lowers the price target from $16 to $14.
Ocular Therapeutix Price Target Cut to $22.00/Share From $24.00 by JMP Securities
Ocular Therapeutix Price Target Cut to $22.00/Share From $24.00 by JMP Securities